Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease

Ananthakrishnan, A. N.; McGinley, E. L.; Binion, D. G.
February 2008
Gut;Feb2008, Vol. 57 Issue 2, p205
Academic Journal
Background: Clostridium difficile is an important cause of diarrhoea in hospitalised patients. An increasing number of cases of C difficile colitis occur in patients with inflammatory bowel disease (IBD)—Crohn's disease (CD), ulcerative colitis (UC). Objective: To estimate the potential excess morbidity and mortality associated with C difficile in hospitalised patients with IBD. Methods: Data from the Nationwide Inpatient Sample (2003) were analysed and outcomes were examined of patients hospitalised with both C difficile colitis and IBD compared with those hospitalised for either condition alone. The primary outcome was in-hospital mortality. A subgroup analysis was also performed comparing outcomes of C difficile infection in patients with CD and UC. Results: 2804 discharges were diagnosed as having both C difficile and IBD, 44 400 as having C difficile alone, and 77366 as having IBD alone. On multivariate analysis, patients in the C difficile-IBD group had a four times greater mortality than patients admitted to hospital for IBD alone )aOR = 4.7, 95% Cl 2.9 to 7.9) or C difficile alone (aOR = 2.2, 95% Cl 1.4 to 3.4), and stayed in the hospital for three days longer (95% Cl 2.3 to 3.7 days). Significantly higher mortality, endoscopy and surgery rates were found in patients with UC compared with CD (p<0.05), but no significant difference in length of stay or median hospital charge between the two groups was seen. Conclusions: C diffcile colitis is associated with a significant healthcare burden in hospitalised patients with IBD and carries a higher mortality than in patients with C difficile without underlying IBD.


Related Articles

  • C. difficile associated with worse outcomes in IBD patients.  // Infectious Disease News;May2011, Vol. 24 Issue 5, p40 

    The article reports on a study published online which found the that inflammatory bowel disease (IBD) patients who contract Clostridium difficile in the hospital are more likely to die in the hospital than hospital patients with IBD alone.

  • A Novel Risk Score to Stratify Severity of Crohn's Disease Hospitalizations. Ananthakrishnan, Ashwin N.; McGinley, Emily L.; Binion, David G.; Saeian, Kia // American Journal of Gastroenterology;Aug2010, Vol. 105 Issue 8, p1799 

    OBJECTIVES:Crohn's disease (CD) is a lifelong relapsing–remitting disease often requiring health-care contact, hospitalization, or surgery. General comorbidity indices were developed to predict mortality, which is rare in this population. There are limited tools to stratify these...

  • Prognosis in Clostridium difficile infection complicating inflammatory bowel disease. Stone, Christian D. // Gut;Feb2008, Vol. 57 Issue 2, p150 

    The author reflects on the effects of a Clostridium difficile infection (CDI) when accompanied by an inflammatory bowel disease (IBD). He informs several studies that illustrate the increasing incidence of CDI, including the studies in the 1980s that show the major role of CDI in the relapse of...

  • Clostridium difficile in toxic magacolon complicating acute inflammatory bowel disease. Bolton, Robin P.; Read, Alan E. // British Medical Journal (Clinical Research Edition);8/14/1982, Vol. 285 Issue 6340, p475 

    Examines the effect of clostridium difficile in toxic megacolon complicating acute inflammatory bowel disease. Cause of acute toxic dilation of the colon; Requirement of surgery when medical intervention fails or colonic perforation occurs; Performance of routine faecal screening for CI...

  • Hospitalizations and Deaths Associated with Clostridium difficile Infection, Finland, 1996-2004. Lyytikäinen, Outi; Turunen, Heli; Sund, Reijo; Rasinperä, Marja; Könönen, Eija; Ruutu, Petri; Keskimäki, Ilmo // Emerging Infectious Diseases;May2009, Vol. 15 Issue 5, p761 

    To determine whether the rate of Clostridium difficile-associated disease (CDAD) and CDAD-related deaths were increasing in Finland, we analyzed registry data from 1996 through 2004. We determined the number of hospital discharges that had a diagnosis code specific for CDAD from the...

  • Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. Ananthakrishnan, Ashwin N.; McGinley, Emily L. // Journal of Crohn's & Colitis;Mar2013, Vol. 7 Issue 2, p107 

    Abstract: Introduction: Serious infections are an important side effect of immunosuppressive therapy used to treat Crohn''s disease (CD) and ulcerative colitis (UC). There have been no nationally representative studies examining the spectrum of infection related hospitalizations in patients with...

  • Clostridium Difficile Infection in Hospitalized Patients at University Clinical Center Tuzla, Bosnia and Herzegovina: a 4 Year Experience. Ahmetagic, Sead; Salkic, Nermin; Ahmetagic, Aldina; Custovic, Amer; Tihic, Nijaz; Smajlovic, Jasmina; Porobic-Jahic, Humera // Materia Socio Medica;Sep2013, Vol. 25 Issue 3, p153 

    Introduction: Clostridium difficile (C. difficile) is currently the leading cause of healthcare-associated diarrhea, but almost nothing is known about the extent of C. difficile infection (CDI) in Bosnia and Herzegovina. Goal: We aimed to retrospectively analyze CDI in hospitalized patients at...

  • Clostridium difficile and IBD. Binion, David G. // Inflammatory Bowel Disease Monitor;2010, Vol. 11 Issue 1, p7 

    The anaerobic spore-forming bacillus, Clostridium difficile (C difficile), has emerged as a serious infection over the past decade, more than doubling in incidence in North American medical centers. Clostridium difficile-associated disease (CDAD), which can range from mild watery diarrhea to...

  • α-Defensins and Clostridium difficile Recent Growing Concerns in Inflammatory Bowel Disease. Savoye, Guillaume // American Journal of Gastroenterology;Dec2008, Vol. 103 Issue 12, p3215 

    A letter to the editor is presented regarding α-defensins and Clostridium difficile in inflammatory bowel disease (IBD).


Read the Article


Sign out of this library

Other Topics